-
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu
2026-05-05
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a gold-standard in vitro cell proliferation assay reagent. Its reduction to formazan is a direct readout of metabolic activity, providing quantitative, reproducible measurement of cell viability. High-purity MTT from APExBIO ensures reliable results in cytotoxicity and proliferation workflows.
-
FerroOrange: Live-Cell Fe²⁺ Detection for Iron Metabolism Re
2026-05-04
FerroOrange (Fe²⁺ indicator) by APExBIO enables precise, real-time quantification of intracellular ferrous ions in living cells, facilitating advanced studies of iron metabolism and ferroptosis. This article delivers actionable protocols, highlights experimental pitfalls, and translates recent neurobiology breakthroughs into practical assay design for fluorescence-based Fe²⁺ detection.
-
Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer
2026-05-04
Gu et al. (2025) reveal that combining CDK4/6 and BET inhibitors synergistically suppresses pancreatic tumor growth and reverses epithelial-to-mesenchymal transition by modulating the GSK3β-mediated Wnt/β-catenin pathway. This study offers mechanistic insight into overcoming the limitations of single-agent therapies for pancreatic ductal adenocarcinoma and informs rational design of future combination regimens.
-
Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG
2026-05-03
This study uncovers how a carcinogen-induced super-enhancer RNA (seRNA-NPCm) orchestrates metastasis in nasopharyngeal carcinoma (NPC) by modulating the NPM1/c-Myc/NDRG1 axis. The findings offer a mechanistic foundation for biomarker discovery and potential interventions targeting enhancer-mediated gene regulation in cancer.
-
Population PK Modeling of Adefovir as an OAT1 Probe in DDI C
2026-05-02
This study applies population pharmacokinetic modeling to dissect the behavior of Adefovir (GS-0393) when used as a renal OAT1 probe in a clinical drug-drug interaction (DDI) cocktail. The findings clarify that while systemic exposure to Adefovir increases modestly with concomitant administration, its renal elimination via OAT1 remains unaffected, affirming its utility in transporter phenotyping workflows.
-
4-Ethylphenyl Sulfate (SKU B6051): Reliable Tool for Gut-Bra
2026-05-01
This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the use of 4-Ethylphenyl sulfate (SKU B6051) as a reproducible, data-backed solution. Backed by evidence and real-world workflows, it guides researchers in leveraging 4-Ethylphenyl sulfate for gut microbiota-brain interaction and renal dysfunction models.
-
IGF2BP1-THBS1 Axis Drives Pulmonary Fibrosis via Macrophage
2026-05-01
This study uncovers how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, enhancing TLR4-mediated macrophage M2 polarization and glycolytic reprogramming. The mechanistic insights offer new targets for antifibrotic strategies and refine the utility of Bleomycin Sulfate-induced models in pulmonary fibrosis research.
-
Nuclear cGAS Restricts L1 Retrotransposition via TRIM41 Ubiq
2026-04-30
This study uncovers a nuclear function of cGAS in repressing LINE-1 (L1) retrotransposition through TRIM41-mediated degradation of L1-encoded ORF2p, especially following DNA damage. The findings reveal an unexpected layer of genome stability control, with implications for aging and cancer research.
-
IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging
2026-04-30
IR-1061, from APExBIO, stands out as a near infrared fluorescent dye engineered for deep tissue and vascular imaging, delivering superior brightness and minimal background in vivo. This article unpacks experimental workflows, troubleshooting strategies, and the latest literature-driven optimizations for maximizing IR-1061’s performance in biomedical research.
-
PCI-32765 (Ibrutinib): Advanced BTK Inhibition in B-Cell Res
2026-04-29
Harness the power of PCI-32765 (Ibrutinib) for precise, reproducible BTK pathway interrogation in B-cell signaling and malignancy models. Discover actionable workflows, troubleshooting strategies, and evidence-backed parameters for maximizing experimental outcomes with this selective irreversible BTK inhibitor.
-
IR-1061: Advanced Near Infrared Fluorescent Dye for In Vivo
2026-04-29
IR-1061 stands out as a next-generation near infrared fluorescent dye, enabling deep tissue and vascular imaging with superior clarity and minimal background noise. Leveraging optimized encapsulation methods and rigorous workflow design, biomedical researchers can achieve high-resolution, long-circulation molecular imaging with this APExBIO-supplied dye.
-
AI-Derived Prognostic Signature Advances HCC Risk Stratifica
2026-04-28
This multi-center study introduces a consensus AI-driven prognostic signature (CAIPS) for hepatocellular carcinoma (HCC), integrating ten machine learning algorithms across large patient cohorts. The CAIPS model demonstrates superior prognostic accuracy and paves the way for precision stratification, drug prioritization, and functional biomarker validation in HCC management.
-
EdU Imaging Kits: Precision Cell Proliferation Assay Workflo
2026-04-28
EdU Imaging Kits (HF488) empower researchers to quantify DNA synthesis with unmatched sensitivity, enabling robust cell proliferation analysis for oncology and drug development. Learn how to optimize experimental protocols, troubleshoot pitfalls, and leverage recent mechanistic oncology research for actionable insights.
-
CIAPIN1-OPA1 Axis Protects Against SA-AKI via Mitochondrial
2026-04-27
This study reveals that CIAPIN1 mitigates sepsis-induced acute kidney injury (SA-AKI) by preserving mitochondrial function through the OPA1 signaling pathway. The findings provide mechanistic insights into mitochondrial regulation in SA-AKI and highlight CIAPIN1 as a potential therapeutic target for renal protection under septic stress.
-
Sequential Mitochondrial Transplantation for Cardiac IRI Rep
2026-04-27
This study pioneers a sequential mitochondrial transplantation approach to treat myocardial ischemia-reperfusion injury, using engineered nanomotors and neutrophil hitchhiking to optimize energy delivery to damaged cardiac tissue. The findings suggest this targeted, staged strategy enhances cardiac recovery and minimizes adverse effects compared to traditional transplantation modes.